Back to results
US 12,551,418 B2Granted
Cosmetic containing ultraviolet wavelength converting substance and medicinal agent
AssigneeShiseido Company, Ltd.
InventorsYusuke Okuyama, Kazuyuki Miyazawa, Nobuyoshi Koga, Tetsuya Kanemaru, Renaud Gillet, Bianca McCarthy
Life of this patent
Estimating the term…
Abstract
Provided is a novel cosmetic containing: an ultraviolet wavelength conversion substance and a drug.
Claims6
A cosmetic comprising
- (A) a UV wavelength conversion substance and
- (B) one or more drugs selected from the group consisting of a derivative of glycyrrhizic acid, a derivative of nicotinic acid, tranexamic acid, a derivative of salicylic acid, and a carboxylic acid represented by formula (I) below, and salts thereof,
- wherein n represents an integer of 2 to 5,
- the (A) UV wavelength conversion substance comprises one or more selected from the group consisting of phycocyanin, vitamin B2, and a zinc oxide phosphor,
- the derivative of glycyrrhizic acid comprises dipotassium glycyrrhizinate,
- the derivative of the nicotinic acid comprises nicotinic acid amide,
- the derivative of the salicylic acid comprises potassium 4-methoxysalicylate, and
- the carboxylic acid represented by the formula (I) comprises 1-piperidine propionic acid.
5 more elements
Dependencies are inferred from the claim text.